- Filed
- Jan 21, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Jan 20, 2026 | 25.99M sh |
| Shares Diluted | Q1 2026 · Nov 30, 2025 | 1.34M sh |
| Shares Diluted restated | Q1 2026 · Nov 30, 2024 | 357.3K sh |
| Capex | Q1 2026 · Nov 30, 2025 | $1.92K |
| Operating Cash Flow | Q1 2026 · Nov 30, 2025 | −$489.75K |
| Operating Cash Flow | Q1 2026 · Nov 30, 2024 | −$663.6K |
| Stockholders Equity | Q1 2026 · Nov 30, 2025 | −$5.49M |
| Stockholders Equity | Q1 2026 · Aug 31, 2025 | $906.68K |
| Stockholders Equity restated | Q1 2026 · Nov 30, 2024 | $1.35M |
| Stockholders Equity | Q1 2026 · Aug 31, 2024 | $1.35M |
| Current Liabilities | Q1 2026 · Nov 30, 2025 | $14.79M |
| Current Liabilities | Q1 2026 · Aug 31, 2025 | $3M |
| Total Liabilities | Q1 2026 · Nov 30, 2025 | $16.12M |
| Total Liabilities | Q1 2026 · Aug 31, 2025 | $4.51M |
| Current Assets | Q1 2026 · Nov 30, 2025 | $1.79M |
| Current Assets | Q1 2026 · Aug 31, 2025 | $2.32M |
| Total Assets | Q1 2026 · Nov 30, 2025 | $10.63M |
| Total Assets | Q1 2026 · Aug 31, 2025 | $5.42M |
| Eps Diluted | Q1 2026 · Nov 30, 2025 | −$4.79 |
| Eps Diluted restated | Q1 2026 · Nov 30, 2024 | −$2.60 |
| Eps Basic | Q1 2026 · Nov 30, 2025 | −$4.79 |
| Eps Basic restated | Q1 2026 · Nov 30, 2024 | −$2.60 |
| Sga Expense | Q1 2026 · Nov 30, 2025 | $394.85K |
| Sga Expense | Q1 2026 · Nov 30, 2024 | $417.41K |
| Net Income | Q1 2026 · Nov 30, 2025 | −$6.44M |
| Net Income | Q1 2026 · Nov 30, 2024 | −$656.89K |
| Operating Income | Q1 2026 · Nov 30, 2025 | −$6.56M |
| Operating Income | Q1 2026 · Nov 30, 2024 | −$693.52K |
| Cost Of Revenue | Q1 2026 · Nov 30, 2025 | $363.46K |
| Cost Of Revenue | Q1 2026 · Nov 30, 2024 | $414.28K |
| Revenue | Q1 2026 · Nov 30, 2025 | $721.73K |
| Revenue | Q1 2026 · Nov 30, 2024 | $766.07K |